Cargando…
A novel peptide (GX1) homing to gastric cancer vasculature inhibits angiogenesis and cooperates with TNF alpha in anti-tumor therapy
BACKGROUND: The discovery of the importance of angiogenesis in tumor growth has emphasized the need to find specific vascular targets for tumor-targeted therapies. Previously, using phage display technology, we identified the peptide GX1 as having the ability to target the gastric cancer vasculature...
Autores principales: | Chen, Bei, Cao, Shanshan, Zhang, Yingqi, Wang, Xin, Liu, Jie, Hui, Xiaoli, Wan, Yi, Du, Wenqi, Wang, Li, Wu, Kaichun, Fan, Daiming |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746182/ https://www.ncbi.nlm.nih.gov/pubmed/19740430 http://dx.doi.org/10.1186/1471-2121-10-63 |
Ejemplares similares
-
Novel peptide GX1 inhibits angiogenesis by specifically binding to transglutaminase-2 in the tumorous endothelial cells of gastric cancer
por: Lei, Zhijie, et al.
Publicado: (2018) -
(68)Ga-Labeled GX1 Dimer: A Novel Probe for PET/Cerenkov Imaging Targeting Gastric Cancer
por: Yin, Jipeng, et al.
Publicado: (2021) -
The function and mechanism of COX-2 in angiogenesis of gastric cancer cells
por: Yao, Liping, et al.
Publicado: (2011) -
Peptide-Mediated Targeting of Cytokines to Tumor Vasculature: The NGR-hTNF Example
por: Corti, Angelo, et al.
Publicado: (2013) -
Immunogenicity of GX301 cancer vaccine: Four (telomerase peptides) are better than one
por: Fenoglio, Daniela, et al.
Publicado: (2015)